Fulphila 6 MG/0.6 ML syringe 0.6ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV699
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,873
Award facts
- Contract value 100% obligated
- $13,873.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $13,873.40, was awarded on January 21, 2026, to AmerisourceBergen Drug Corp for the supply of Fulphila 6 mg/0.6 mL syringes. The contract is a firm fixed-price, non-set-aside award under the Defense Logistics Agency's Medical Supply Chain and will be completed by January 22, 2026. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with the DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs with an extensive portfolio of brand-name and generic medications, vaccines, and medical devices. As the parent company, Cencora, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical extending through December 31, 2031, positioning the organization as a critical vendor for military treatment facilities and veterans' healthcare programs. Both the prime contractor and parent company compete on a full and open basis for federal contracts, as evidenced by the non-set-aside status of this award.
Quick answers
Who was awarded contract SPE2DR26FV699?
SPE2DR26FV699 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FV699 worth?
The government has obligated $13,873 on SPE2DR26FV699.
Is contract SPE2DR26FV699 an order under another contract?
Yes. SPE2DR26FV699 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV699 competed?
The extent of competition for SPE2DR26FV699 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award